Press "Enter" to skip to content

New patent expiration for MERCK drug FOSAMAX PLUS D

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for MERCK drug FOSAMAX PLUS D

Annual Drug Patent Expirations for FOSAMAX+PLUS+D
Annual Drug Patent Expirations for FOSAMAX+PLUS+D

Fosamax Plus D is a drug marketed by Merck and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.

FOSAMAX PLUS D drug price trends.

Drug patent litigation for FOSAMAX PLUS D.

The generic ingredient in FOSAMAX PLUS D is alendronate sodium; cholecalciferol. One supplier is listed for this compound. Additional details are available on the alendronate sodium; cholecalciferol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for MERCK drug FOSAMAX PLUS D
Do NOT follow this link or you will be banned from the site!